NASDAQ · MRX
Marex Group Limited financials
$72.13+1.18%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $2.72B | $2.13B |
| Gross profit | $1.87B | $1.37B |
| Gross margin | 68.9% | 64.2% |
| Operating income | $247.3M | $60.7M |
| Net income | $293.9M | $204.7M |
| Net margin | 10.8% | 9.6% |
| Diluted EPS | $3.86 | $2.72 |
| EBITDA | $283.4M | $89.5M |
| Operating cash flow | $667.5M | $1.16B |
| Free cash flow | $654.4M | $1.15B |
| Diluted shares | 76.1M | 75.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $2.88B | $2.56B |
| Short-term investments | $16.63B | $12.51B |
| Total debt | $17.78B | $12.72B |
| Total assets | $34.68B | $24.31B |
| Total liabilities | $33.41B | $23.34B |
| Shareholders' equity | $1.26B | $976.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology